Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 16,215 | -4,419 | -17,426 | -25,002 | -17,803 |
| Depreciation Amortization | 113,126 | 76,543 | 38,283 | 138,939 | 95,835 |
| Income taxes - deferred | -1,815 | -682 | -46 | -8,391 | -7,313 |
| Accounts receivable | 1,268 | 15,640 | 3,993 | -21,780 | -34,063 |
| Accounts payable and accrued liabilities | 106 | -1,075 | -502 | -707 | 3,436 |
| Other Working Capital | 23,833 | 15,005 | -24,861 | -12,713 | -36,261 |
| Other Operating Activity | 48,678 | 26,381 | 28,230 | 53,884 | 54,074 |
| Operating Cash Flow | $201,411 | $127,393 | $27,671 | $124,230 | $57,905 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,000 | N/A | N/A | N/A | N/A |
| PPE Investments | -297 | -232 | -176 | -1,622 | -682 |
| Net Acquisitions | N/A | N/A | N/A | -572,069 | -572,069 |
| Purchase Of Investment | -51,418 | -41,661 | 0 | N/A | 0 |
| Investing Cash Flow | $-45,715 | $-41,893 | $-176 | $-573,691 | $-572,751 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 235,220 | 235,220 | 235,654 | 517,682 | 517,682 |
| Debt Repayment | -255,305 | -209,471 | -163,638 | -75,000 | -50,000 |
| Common Stock Issued | 5,861 | 5,268 | 4,017 | 12,148 | 5,285 |
| Common Stock Repurchased | -50,000 | N/A | N/A | -14,063 | -6,422 |
| Other Financing Activity | -8,128 | -7,956 | -7,736 | -4,044 | -3,999 |
| Financing Cash Flow | $-72,352 | $23,061 | $68,297 | $436,723 | $462,546 |
| Beginning Cash Position | 176,235 | 176,235 | 176,235 | 188,973 | 188,973 |
| End Cash Position | 259,579 | 284,796 | 272,027 | 176,235 | 136,673 |
| Net Cash Flow | $83,344 | $108,561 | $95,792 | $-12,738 | $-52,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | 201,411 | 127,393 | 27,671 | 124,230 | 57,905 |
| Capital Expenditure | -297 | -232 | -176 | -1,622 | -682 |
| Free Cash Flow | 201,114 | 127,161 | 27,495 | 122,608 | 57,223 |